Skip to main content
Top

Current Oncology Reports

Issue 8/2023

Content (11 Articles)

Open Access Rituximab

Hairy Cell Leukemia: Where Are We in 2023?

Andres Mendez-Hernandez, Krishna Moturi, Valeria Hanson, Leslie A. Andritsos

Open Access Cytokines

Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data

Erin E. Crotty, Ashley L. Wilson, Tom Davidson, Sophia Tahiri, Juliane Gust, Andrea M. Griesinger, Sujatha Venkataraman, Julie R. Park, Sabine Mueller, Brian R. Rood, Eugene I. Hwang, Leo D. Wang, Nicholas A. Vitanza

Intratumoral Immunotherapy: Is It Ready for Prime Time?

Mario Ghosn, Lambros Tselikas, Stéphane Champiat, Frederic Deschamps, Baptiste Bonnet, Émilie Carre, Marine Testan, François-Xavier Danlos, Siham Farhane, Sandrine Susini, Steve Suzzoni, Samy Ammari, Aurélien Marabelle, Thierry De Baere

Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder

Michelle Lee, Aseala Abousaud, R. Andrew Harkins, Ellen Marin, Deepali Balasubramani, Michael C. Churnetski, Deniz Peker, Ankur Singh, Jean L. Koff

Immunotherapy in Head and Neck Cancer: Where Do We Stand?

Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, Fotis Panagopoulos, Eleni Geladari, Irene Karampela, Theodora Stratigou, Maria Dalamaga

Open Access NSCLC

Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer

Jay Parekh, Kaushal Parikh, Joshua E. Reuss, Alex Friedlaender, Alfredo Addeo

Open Access CNS Metastasis

Diagnostic and Therapeutic Updates in Leptomeningeal Disease

Meaghan A. Roy-O’Reilly, Tyler Lanman, Amber Ruiz, David Rogawski, Brian Stocksdale, Seema Nagpal

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine